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Introduction: Bone fragility in children and youth with Type 1 Diabetes (DM1) may relate to 
weaker bones and muscles, but the evidence is limited. The objectives of my thesis were (1) to 
compare bone and muscle properties and strength between children with and without DM1, and 
(2) to explore if muscle outcomes are mediators explaining the bone differences between 
children with and without DM1. 
Methods: I included 25 children with DM1 and 168 typically developing children and youth 
(age 6-15yrs) in my thesis. Their bone properties and muscle size were measured using 
peripheral quantitative computed tomography (pQCT). Muscle force was assessed using 
neuromuscular performance measures, including maximal grip force, push-up, countermovement 
and long jump tests. I compared bone and muscle properties and strength between children with 
and without DM1 using MANCOVA followed by pairwise comparisons (1st objective). I added 
muscle size and force into regression models as possible mediators to assess if muscle outcomes 
are mediators helping explain the potential bone difference between children with and without 
DM1 (2nd objective). 
Results: There were group differences in bone and muscle properties and strength (p<.05). 
Cortical area was 7% and 10% lower and density was 8% higher and 5% higher at radius and 
tibia shafts, respectively, in children with DM1. Children with DM1 also had 6% lower cortical 
content at tibia shaft. There was no difference at the distal radius or tibia bone properties and 
strength between groups. Children with DM1 had 12% higher maximal push-up force. Lower leg 
muscle area was a mediator for tibia shaft cortical bone content and area difference between 




Conclusion: Children with DM1 had smaller cortical area but higher density at the radius and 
tibia shafts. Lower leg muscle area was a mediator explaining the lower tibia shaft cortical bone 
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Type 1 diabetes (DM1), a life-long disease with insulin deficiency, is predominantly 
diagnosed in childhood 1,2. Individuals with DM1 have higher fracture risk throughout their life 
2–4, which is potentially associated with lower bone strength 5. Fracture, especially hip fracture in 
older age, can seriously affect the life quality and increase the risk of dying 6,7. Recent research 
has reported children with DM1 have 14-40% higher fracture risk than their typically developing 
peers 2, which suggests the increased fracture risk begins at childhood and may relate to poor 
bone development in children with DM1. Therefore, understanding bone properties and strength 
is crucial to characterize bone development in children with DM1 8,9.   
Peripheral quantitative computed tomography (pQCT), a commonly used 
musculoskeletal imaging tool for reliable assessment of bone geometry and estimation of bone 
strength in children 10. Previous studies reported various findings comparing bone properties and 
strength in children with and without DM1 characterized by pQCT. At radius, there have been 
studies reporting children with DM1 had lower trabecular bone mineral density 11 at the distal 
site. There were also publications indicating lower total bone area 12, cortical bone area and 
density 12,13, and bone strength 12 at radius shaft site. For tibia, there was lower total bone area 
and content 12, trabecular bone area, density and content 14–17 reported in children with DM1 at 
distal site. There was lower total bone content 12, cortical bone area, density and content 12,14,17, 
and bone strength 15,17 reported at tibia shaft. However, interestingly, there was one study 
reporting higher cortical bone mineral density at tibia shaft 17. Also, the findings at the same 
measurement site were not consistent across different studies 13,15–17. Besides pQCT, different 
imaging tools, dual x-ray absorptiometry (DXA) and magnetic resonance imaging (MRI), have 
been used to measure bone in children with DM1 in previous studies 12,14,16–21. Recent research 
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with MRI reported lower trabecular bone micro-structure parameters at proximal tibia 18. The 
results from DXA studies seemed conflicting, while some studies reported normal total body and 
lumbar spine bone mineral content, area and density 17,20,22–25, and others reported lower lumbar 
spine bone mineral content and density 12,26. A metacarpal study using digitized x-ray reported 
smaller and weaker bone in children with DM1 27. 
Optimal muscle development is essential for bone growth in children with DM1 due to 
the strong relationship and interaction between muscle contraction force and bone strength 8,9. 
The force produced by muscle contraction is one of the primary sources of stimulus for bone 
strength development 28,29, and the maximal muscle power is an indicator of bone strength in 
children 30. Thereby maximal muscle voluntary contraction assessed by neuromuscular 
performance is especially meaningful to be measured. Fricke et al. reported children with DM1 
had lower grip force 31, but Bechtold et al. reported participants with DM1 had higher grip 
strength than typically developing children reference data 13. Lukacs et al. reported only younger 
boys (8-12yrs) with DM1 shew lower grip force 32. For jumps, Maratova et al. reported 
adolescents with DM1 had normal maximal muscle force and power but significantly lower 
maximal relative leg muscle force (maximal force/body mass) and power (maximal power/body 
mass) during countermovement jump comparing to reference data 15. On the other side, muscle 
cross-sectional area (MuA), referred to muscle size, obtained from bone imaging tools is a good 
surrogate of muscle force 13,28,33,34. Only few previous studies measured MuA in children with 
DM1. Moyer-Mileur et al. reported higher MuA in adolescents with DM1 than typically 
developing reference at baseline using pQCT measures 17. Bechtold et al. only reported lower 
MuA in pre-pubertal children with DM1 but not in adolescents 13.  
However, to my knowledge, there is no previous study exploring the role of muscle size 
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or force in the relationship of DM1 and bone outcomes. In particular, the role of muscle 
outcomes as potential mediators in the relationship between DM1 and bone outcomes has not 
been explored. Previous research focused more on the interaction between muscle and bone 
during growth in children with DM1, which the muscle contraction can provide stimulus to bone 
adaptation and improve bone strength 35. The findings from previous studies reported diversely 
on the potential difference of muscle-bone interaction between children with and without DM1. 
Moyer-Mileur et al. reported DM1 adolescents to have significantly lower total bone content to 
MuA ratio than typically developing reference (age 12-18yrs) 17. Bechtold et al. reported a 
significant correlation between lower MuA and total and cortical area at radius shaft in young 
DM1 children (mean age 9.7yrs), suggesting that children with DM1 have smaller muscle and 
bone, which can be explained by muscle-bone interaction 13. On the other side, Maratova et al. 
did not report any difference in terms of muscle-bone relationship when comparing to Czech 
national reference data 15. However, it is still not well understood the role of muscle in the 
relationship between DM1 status and possibly differed bone outcomes.  
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1.0 Background Literature 
The scope of this literature review is to understand the musculoskeletal properties, 
strength, and development in children. 
 
1.1 Bone Physiology 
Bone is a dynamic living tissue which is composed of organic and inorganic materials 
and has several vital functions in our body 36,37. The first one is to support and connect with 
skeletal muscle to achieve physical movement 36. As a dynamic tissue, bone will respond to 
external forces like muscle contraction and mechanical loading and signaling from, for instance, 
hormones and growth factor 36. In addition, bone is a rigid tissue that can protect the organs. 
Furthermore, bone can serve as a storage of calcium and phosphate for serum homeostasis 36. 
Long bone is wider at two ends (epiphyses) and cylindrical shaped in the middle with a 
medullary cavity at the center (midshaft or diaphysis) 36. There is also a transition zone in 
between the epiphysis and diaphysis, which is called metaphysis 36. There are two types of bone 
in long bone structure, cortical and trabecular bone, characterized by density and porosity. 
Cortical bone is denser and more calcified (80-90%) comparing to trabecular bone which is more 
porous and less calcified (15-25%) 36. Cortical bone has two surfaces, an outer surface 
(periosteal) and an inner surface (endosteal) 36.  
From the biological view, there are three types of bone cells, osteoblasts, osteoclasts and 
osteocytes. Osteoblasts and osteocytes work together for bone formation, and osteoclasts are for 
bone resorption. Osteoblasts will produce the unmineralized bone, osteoid, which will develop 
into mature bone eventually. Osteocytes are inactive osteoblast cells and able to help with 
maintaining the tissue produced by osteoblasts. Another main function of osteocytes is to sense 
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where and how much mechanical strain the bone is experiencing 36–38.  
 
1.1.1 Bone Growth, Modeling and Remodeling 
Long bone increases its lengths by endochondral ossification that occurs at the growth 
plate between the epiphysis and metaphysis 39. At the growth plate, resting chondrocytes, also 
known as stem cells, align toward the direction of bone growth and ultimately develop into 
trabeculae and form trabecular bone 39. As long as new material is adding into the zone of the 
growth plate, the bone will calcify and gain length 39. Along with growth, the metaphysis will get 
farther from the growth plate. Consequently, the trabecular bone at the center of bone at 
metaphysis will become thinner and eventually be resorbed. Contradictorily, the trabecular bone 
at outer metaphysis will thicken and finally build to a cortical cortex 39. This process is called 
metaphyseal inwaisting, in which the original metaphysis becomes smaller in size until it attains 
the size of the diaphysis. In this way, bone grows longer 39,40. 
Besides increasing length, bone also needs to expand in width; otherwise, bone is likely 
to be unstable and prone to fracture 39. Bone modeling is the process bone enlarged in diameter, 
and remodeling is the process of bone turnover, in which old bone tissue is removed and 
replaced by new bone tissue 41,42. Both modeling and remodeling involve bone cells osteoblast 
and osteoclast 37,42. Modeling is a combination of work from osteoblast and osteoclast cells on 
opposite sides of bone 42. During growth, osteoclasts resorb bone tissue from the endosteal 
surface of a bone, and osteoblasts form more bone tissue on the periosteal surface. Thus, there 
will be more bone formed comparing to the bone removed, by which both the size of the bone 
and marrow cavity will expand 42. 
Bone remodeling formats with continuous bone formation and resorption cycling on the 
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same bone surface 42. During remodeling, osteoblasts and osteoclasts work together, which 
osteoclasts take off some bone tissue which is then later replaced by osteoblasts with a reversal 
phase in between 42. The osteoblast and osteoclast cells in this process collectively are called the 
“basic multicellular unit”, and the osteoblasts and osteoclasts working together during the 
remodeling process are referred to as “coupling” 42. There is a balance for the “coupling” 41,42. 
Remodeling is followed by the “Activation-Resorption-Reversal-Formation” process performed 
by the “basic multicellular unit” 36. The osteoclasts are activated first before the resorption 
process which then is terminated by reversal phase 36. Afterward, osteoblasts take place to start 
the formation phase (Figure 1) 36. During growth, there is more bone formation going on 
comparing to bone resorption; thereby more bone is gained. On the other hand, during aging, 
more resorption takes in place, which explains bone loss 42. For young adults, the remodeling 
“coupling” is balanced so that the amount of bone is maintained 42. 
 
Figure 1: Diagram showing “Activation-Resorption-Reversal-Formation” process of bone 
remodeling. Adapted from Moreira et al. (2000) 36 
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1.1.2 “Mechanostat” and “Mechanotransduction” 
“Mechanostat” is a hypothesis that human can maintain bone health from adapting daily 
load bearing by balancing a combination of modeling and remodeling and their thresholds, bone 
marrow mediator, signaling mechanisms 43. Other factors, like hormone, would serve as 
modulator in the “Mechanostat” model and help carry out this process 43. If mechanical loading 
would add more strain to the bone, the modulator will send the signal that extra bone strength is 
needed to adapt to the higher strain. Then this will trigger the bone modeling and remodeling 
process to put on more bone tissue to achieve the targeted bone strength (Figure 2) 43. The lowest 
strain required to activate bone remodeling, modeling and repair processes is called minimal 
effective strain (MES) 44. If the strain that bone experiences does not reach the remodeling MES, 
there would be no response 44. If the strain reaches the remodeling MES, the remodeling process 
would likely take in place, and the net bone mass would be maintained 44. If the strain exceeds 
the modeling MES but not repair MES, there would be more bone formed and potentially 
increase the bone mass and strength 44. However, if the strain is over repair MES, it would not be 
beneficial and is likely to cause some microdamage or even fracture to the bone 44. The bone 
adaptation responding to mechanical loading is coordinated based on the theory of 
“Mechanotransduction”, which is a process that bone would turn mechanical stimuli toward bone 
into biochemical response 45,46. The steps involve mechanical coupling, biochemical coupling, 
cell-to-cell signaling and cell response 45.  
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Figure 2: Sample diagram showing with increasing the bone strain to reaching specific MES, 
bone will go under remodeling, modelling and repair which will either maintain or gain bone 
mass. With reaching the physiologic zone, remodeling will help keep the overall bone mass and 
no new bone was gained. After reaching the overload region, modeling will take in place and 
more bone will be formed. Diagram adapted Forwood & Turner (1995) 
 
1.1.3 Other Biological Factors Influencing Bone Growth 
There are also other biological factors associated with muscle and bone development in 
general children, like sex, age and maturity, anthropometry, physical activity, nutrition intake. 
Sex is an essential factor to consider because boys and girls are underline different 
growth patterns and will develop into different body stature during and after puberty. Boys 
experience higher bone turnover rate, longer growth duration, and higher peak height velocity 
than girls 47; therefore, it is necessary to identify the influence of sex differences in bone and 
muscle on children. 
Age and Maturity are also crucial factors assessing bone in children. However, since the 
timing of maturation is different in boys and girls, chronological age is not able to fully represent 
sex-specific maturity 48. Besides, maturity has been previously indicated as a predictor of bone 
geometry and strength 49–52. Thereby, maturity is preferred compared with age when controlling 
timing in growth and development. During maturation, the maximal linear growth speed is 
referred to peak height velocity 47. Instead of using the Tanner stage to characterize secondary 
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sex maturation, maturity offset (MO), the years from the age at peak height velocity, is more 
appropriate assessing somatic maturation, or skeletal growth, in children 53. Moreover, since 
boys and girls are not underline the same tempo and timing on both sexual and somatic 
maturation, it is tough to align the sex maturation in boys and girls to somatic maturation 53. 
Also, since the Tanner stage is characterized by stages, not continuous number, even children 
under the same stage of maturity may still be slightly different in maturation progress. MO is a 
continuous measure and calculated by sex-specific formulae built from regression models based 
on longitudinal growth data in children 48. Hence, MO is easier to align with growth and somatic 
maturity compared to categorical measure Tanner stage. Therefore, MO is preferable when 
characterizing somatic maturity in children. 
Anthropometry, height and body mass specifically, is positively correlated to bone 
status in children 54–56. Limb length, a determinant of bone strength, is proportional to body 
height 57,58, but it is still questionable for the reliability of limb length assessment due to the 
palpation or measurement errors using a sliding caliper. In addition, heavier children tend to have 
stronger bones, especially the tibia, and muscles to support their body weight and daily 
movement 59. 
Physical Activity is a critical component during growth and development 60 and 
associated with bone strength 60,61. Canadian Physical Activity Guidelines for children and youth 
(5-17yrs) recommend 60mins moderate-to-vigorous physical activity per day, and at least three 
times of vigorous physical activity and muscle and bone-strengthening exercise per week 62. 
High impact physical activities, like jumps, can provide loading to the bone and help improve the 
bone strength 60,63.  
Nutrition Intake of calcium, Vitamin D and protein also influences bone growth in 
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children 64–67. Calcium is associated with areal bone mineral density across different skeletal sites 
in both boys and girls 64, and is also a determinant of bone strength at the tibia in children 28. 
Vitamin D, usually characterized by 25-hydroxyvitamin D (25(OH)D) status, may help to reduce 
the HbA1c level, the indicator of glycemic control, in children with DM1 68–70. However, 
insufficient (25(OH)D = 50-75nmol/mL) and deficient Vitamin D (25(OH)D < 50nmol/mL) 
intake will increase the risk of developing osteoporosis and fracture in both children and older 
adults 65,71,72. Severe deficiency in Vitamin D (25(OH)D < 10nmol/mL) could develop into 
ricket, which will cause inadequate bone mineralization and impair bone growth in children 66. 
Protein is another factor influencing bone and muscle growth in children. Protein intake is 
positively associated with bone properties and strength, like bone mineral content, density and 
area 67,73, and also influences bone development via hormones 74. However, overtaking of protein 
may also elevate bone resorption 73. Accordingly, calcium, Vitamin D, and protein intake can be 
factor influencing bone growth in both children with and without DM1. 
 
1.1.4 Type 1 Diabetes (DM1)   
Type 1 diabetes (DM1), a life-long disease with insulin deficiency, is predominantly 
diagnosed in childhood 1,2. This disease can be caused by multiple risk factors, especially genetic 
and environmental 75. Worldwide, there are about 0.02% children (0-14yrs) with DM1, and the 
reported increase of incidence rate is 2-5% per year 76,77. Canada has one of the highest increases 
in the rate of pediatric DM1 incidence around the world 76–78, which should draw more attention 
to the potential effect of DM1 on growth and development in children with DM1.  
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1.1.4.1 Glycemic Control and Musculoskeletal Growth in Children with DM1 
Glycemic control may influence bone development in children with DM1. Glycemic 
control, i.e., how well DM1 is managed, is usually monitored by glycated hemoglobin 
(Hemoglobin A1c [HbA1c]) test. Typically HbA1c is tested approximately every three months, 
and the average HbA1c is assessed by the average of the tests across the year 21. According to 
American Diabetes Association guidelines, HbA1c under 58 mmol/mol or 7.5% will be 
considered under good glycemic control, and HbA1c equal or above 58 mmol/mol or 7.5% will 
be considered under poor glycemic control 14,21. The previous studies reported with poor 
glycemic control, children with DM1 may have or develop into lower bone mineral density 
compared to children with good glycemic control in both cross-sectional and longitudinal studies 
14,21,79–81. Poor glycemic control also potentially increases the risk of fracture and the 
development of osteoporosis later in lives 80.  
 
1.1.4.2 Bone Assessment in Children with DM1: Bone Biomarkers 
Bone biomarkers, including bone formation and resorption and regulators of bone 
turnover released during growth, are commonly used to monitor bone remodeling or turnover, 
which provides information about skeletal growth and development in children. The common 
biomarkers for bone formation are alkaline phosphatase (ALP), osteocalcin (OC), procollagen 
type 1 N-terminal propeptide (P1NP), and procollagen type 1 C-terminal propeptide (P1CP). The 
popular biomarkers for bone resorption are parathyroid hormone (PTH), 25-OH-vitamin D (25-
OH-D), (urinary) deoxypyridinoline (DPD), carboxy-terminal crosslinked telopeptide of type 1 
collagen (CTX-1) and receptor activator of NF-kB ligand (RANKL). Regulators of bone 
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turnovers include dickkopf-1 (DDK-1) and sclerostin. Other than bone turnover markers, 
calcium, phosphorus, growth hormone and insulin-like growth factor 1 (IGF-1), can also indicate 
bone growth in children.  
The emerging evidence has suggested altered bone turnover in children with DM1 from 
biomarkers 18,19,27,82–84. However, the findings are not very consistent in terms of higher 27 or 
lower biomarkers 18,19,83,84. The potential reason underneath the altered bone turnover rate in 
children with DM1 may link to the reduced osteoblastic activity and osteoclast signaling 
associated with DM1 itself 83. 
 
1.2 Bone and Muscle Imaging Tools  
There are six types of imaging tools commonly used to measure bone and muscle in 
children and youth. Below is a brief introduction of each imaging technique previously used in 
research as well as their corresponding bone and muscle related findings in children or 
adolescents with DM1. 
 
1.2.1 Dual-Energy X-Ray Absorptiometry (DXA) 
DXA is the most widely used two-dimensional bone imaging technique for both clinical 
and research purposes (Figure 3) 85,86. Clinically, it is a valid tool to diagnose osteoporosis and 
estimate fracture risk with good measurement precision (CV% = 1-2%), low radiation dose, 
relatively low cost and short scan time 85,87. For research, it can measure bone mineral content 
(BMC, g), areal bone mineral density (aBMD, g/cm2), and bone area (BA, cm2) for total body as 
well as clinically relevant sites like the lumbar spine and proximal femur 85. Not only for bones, 
DXA can also assess body composition and calculate muscle and fat mass 85. However, the 
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limitations of DXA are unneglectable owing to the two-dimensional projection on three-
dimensional bone structure 85. Firstly, it is not possible to detect bone geometry and separate 
cortical and trabecular bone properties 85. Secondly, the X-ray attenuation is influenced by bone 
marrow and soft tissue (like subcutaneous fat and muscle) surrounding bone 85. Especially in 
children under rapid growth, x-ray penetration might be different if monitoring longitudinally, by 
which their body composition may change greatly, and potentially affect the consistency and 
accuracy of measurement results 88. 
DXA findings are varible in children with DM1. Children with DM1 have been shown 
with lower total-body BMC, aBMD and BA 16–18, lumbar spine BMC, aBMD and BA 17,18, 
femoral neck and head aBMD 12,14,16, great trochanter BMC 12. However, there were also studies 
which did not report difference on any of DXA bone parameters comparing children with DM1 
to controls or reference 19–21. 
 
 
Figure 3: Sample DXA images of total body (left) and lumbar spine 1-4 (right) obtained from 6-
year-old child. Adapted from Di lorgi et al. (2018) 86 
 
 14 
1.2.2 Quantitative Computed Tomography (QCT) 
QCT is a bone imaging technology combining computed tomography (CT) and a 
calibration standard to obtain bone size, density and content 86. It can scan regions of interest 
from total body and measure the “true” volumetric bone mineral density (BMD, g/cm3) with 
good accuracy and reproducibility (CV% < 3%) 86. It can also measure bone structure and 
geometry, like bone mineral content (g) and cross-sectional area (cm2), and separate trabecular 
and cortical bone, and the common scanning sites are the lumbar spine (Figure 4) and femoral 
midshaft 86. However, QCT (0.8µSV per central area scan in 10yrs old child) has a relatively 
higher radiation dose and cost compared to DXA (0.02µSV per spine scan in 10yrs old child) 86.  
There was one study related to children with DM1, which reported lower cortical bone 
mineral density at the lumbar spine but not trabecular density 89. 
 
Figure 4: Sample QCT image for lumbar spine 1-3. The red lines in the lower images locate at 
midplane of each vertebra viewed from sagittal plane. The red oval regions in the upper images 
are located at the midplane characterized from the lower images, and the circled area is used to 
calculate the bone mineral density. Adapted from Adams (2016) 87 
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1.2.3 Peripheral Quantitative Computed Tomography (pQCT)  
Peripheral quantitative computed tomography (pQCT) is a commonly used peripheral CT 
scanner in pediatric measurement. It is a portable device designed to image the peripheral 
skeleton, particularly the upper and lower limbs, like radial and tibial bone structure and 
geometry as well as the surrounding muscle, with relatively low radiation (lower than 0.1µSV per 
scan including scout view) 10,86,90. The precision error of pQCT has been determined in bone 
properties and strength measures in children 10. The main bone parameters measured by pQCT 
are total, cortical and trabecular bone area, content and density from different sites on the radius 
and tibia in children. Cortical and trabecular bone is separated by density thresholds and 
algorithms 10. Bone area and geometry (material distribution over the cross-section of bone) are 
crucial when estimating bone strength at a long bone 10,91. The formulae for bone strength 
estimation have been validated at the distal and shaft sites of the radius and tibia 10,91. At the 
distal site, the bone strength is estimated against compressive loading, which is calculated by 
multiplying total bone area and squared total bone density. At shaft site, bone strength is 
represented by polar sectional modulus against torsional loading 10. The precision errors of bone 
properties range from 2-19% for distal sites, and 2-8% for shaft sites 10. pQCT is also able to 
measure muscle cross-sectional area (MuA), a surrogate measure of muscle force 92. It can 
separate the muscle from bone and subcutaneous tissue by density threshold and algorithm as 
well 10,93,94. The precision errors of MuA from our lab range from 3-4%.  
However, there is a limitation, partial volume effect, related to all CT scans, since the CT 
images are constructed by pixels 85. There are always some pixels which are not fully filled or 
filled by tissues with different densities, which may underestimate averaged bone density 85. For 
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instance, a “red low-density ring” at the periosteal surface of the cortical cortex (Figure 5), which 
is a combination of cortical bone and muscle tissue in the pixels when calculating total bone 
density, might result in some underestimation in bone density assessment 85. 
 
Figure 5: Sample pediatric pQCT images of distal radius (left) and radius shaft (right) at 4% and 
65% of ulna length, respectively. The white/blue color structure is with higher density, and red 
color structure is with lower density. Yellow arrows point at the “red lower-density ring” caused 
by partial volume effect where pixels contain both cortical bone and muscle tissue.  
 
Previous studies reported various findings comparing bone properties and strength in 
children with and without DM1 obtained by pQCT. Saha et al. measured dominant radius and 
right tibia in DM1 adolescents 12. They reported lower total bone mineral content and area at the 
distal tibia, and lower total bone mineral content and cortical bone area at the radius and tibia 
shaft when compared to their typically developing peers. Their findings also suggested lower 
bone strength (density-weighed polar section modulus, SSIp) at the radial and tibial shaft, but not 
for distal sites (cortical to total bone area ratio) (Table 1) 12. SSIp is the ability of bone to resist 
torsional loading, which is related to bone geometry, bone size, bone tissue distribution, and 
material property and stiffness at the diaphysis 91. Bechtold et al. measured the non-dominant 
radius using pQCT from DM1 children with different maturation status 13. They reported lower 
trabecular bone density at distal sites in girls, and total and cortical bone area at the shaft in both 
sexes comparing to typically developing reference. However, the largest difference was detected 
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in pre-pubertal DM1 participants, not in adolescents (Table 1) 13. Maratova et al. measured the 
non-dominant tibia in DM1 adolescents and reported lower trabecular bone density at the distal 
site and bone strength (SSIp) at the shaft (Table 1) 15. Moyer-Mileur et al. scanned non-dominant 
tibia in DM1 children 17. They reported lower distal-site trabecular bone and shaft-site cortical 
bone content,  density and area except cortical bone mineral density and shaft bone strength 
(SSIp) at baseline (Table 1) 17. Another study from the same lab reported lower trabecular bone 
density at the distal tibia (Table 1) 16. Weber et al. reported lower distal tibia trabecular bone 
density and tibia shaft cortical bone density in children who were diagnosed with DM1 within 
one month at baseline, but only detected lower distal tibia trabecular density at 12-month follow-
up. However, they did not report any differences on the non-dominant radius bone properties 
between children with and without DM1 (Table 1) 14
 
1.2.4 High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) 
HR-pQCT is an upgrade version of pQCT, and can measure the three-dimensional bone 
micro-structure from distal radius and tibia with relatively low radiation dose (<4µSV per scan) 
and precision errors smaller than 7% in children 95,96. It can separate cortical cortex from the 
trabecular bone at the distal radius and tibia. HR-pQCT takes 110 slices over a 9.02mm region, 
which allows 3D visualization of distal radius and tibia (Figure 6) 97. The trabecular bone 
outcomes are trabecular number (Tb.N), thickness (Tb.Th) and separation (Tb.Sp) 96. The 
common cortical bone outcomes are thickness (Ct.Th), porosity (Ct.Po), bone volume/total 
volume (BV/TV) 96. Finite-element models can also be built from the scan images to assess bone 
biomechanical strength noninvasively, like failure load, which estimates how much force bone 
can undertake before fracture 81,86. It can also measure the parameters that pQCT measures, 
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which are total, cortical and trabecular bone area, and cortical and trabecular bone density at the 
distal ends of radius and tibia 96. However, although there is a protocol using HR-pQCT in the 
pediatric population, the software was initially developed for adults.  
There were no previous studies assessing bone micro-structure with HR-pQCT in 
children with DM1. The adult study reported lower total and cortical bone mineral density, and 
cortical bone thickness in DM1 group comparing to the control group (mean age 46yrs in both 
groups) 98. 
 
Figure 6: Sample pediatric distal tibia scan from our lab with 3D visualization (left) and 
separated cortical shell and trabecular bone (right). The outer blue cortex is the cortical cortex 
with intracortical pores labelled in brown. Trabecular bone is inside the cortical cortex with 
green color.  
 
1.2.5 Quantitative Ultrasound (QUS) 
QUS is a radiation-free and portable device to assess the bone mineral status and stiffness 
at a low cost 54. Similar to DXA, QUS is also not able to separate cortical and trabecular bone. 
The most common scanning site is the heel, but it can also measure fingers, radius and tibia. The 
bone parameters obtained from QUS scan are speed of sound (m/s) and broadband ultrasound 
attenuation (dB/MHz) with precision error up to 6% 86,99,100. Like DXA, one downside of this 
technique is the measurement results can be interfered by soft tissue thickness 86, since the 
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ultrasound wave can be scattered and absorbed by not only bone tissue but also bone marrow and 
the soft tissue surrounding bone 96. Therefore, the ultrasound is often used at heels since there is 
less soft tissue. In addition, QUS does not provide a direct conversion to bone density, and the 
correlation between QUS parameters and densitometry measures from other devices, DXA for 
instance, remains questionable 100,101. 
 
1.2.6 Magnetic Resonance Imaging (MRI) 
To form an image, MRI detects the excitation of hydrogen protons in a high magnetic 
field 86. It is a non-invasive technology with no radiation. It can assess the micro-structure for 
soft tissues and both the trabecular and cortical bone, like HR-pQCT, with good short-term 
precision errors (CV% = 1-3%) in adults and children 86. MRI is also able to measure various 
sites of the body, including both central part of the body and peripheral bones (Figure 7) 86. 
However, MRI scanning is costly and noisy, and the accessibility is limited since most MRI 
devices are for clinical use 86. The setting of MRI scanning environment is not ideal for children, 
since parents are not allowed to stay during the scan 86,96. 
The recent study in children with DM1 with MR1 reported lower bone volume to total 
volume, trabecular number and separation at the proximal tibia, which suggests a deficiency in 
trabecular bone in children with DM1 (Table 1) 18. 
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Figure 7: Sample pediatric lower leg MRI scan. Adapted from Whitney et al. (2017) 102
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Table 1: Summary of previous studies assessing bone and muscle with imaging tools on children or adolescents with DM1 
 
Author Year Study Design Participant Imaging Tools Findings 
Roe et al. 1991 Cross-
sectional 
48 children with DM1 
and 48 controls (mean 
age 12.8yrs)  
 
QCT Lower cortical but not trabecular bone mineral 





21 children with DM1 
(mean age 12.6yrs) and 
sex- and age-matched 
controls (mean age 
12.8yrs) 
 






23 children with DM1 
and 17 age, height, and 
pubertal status matched 
controls (mean age 
9.5yrs)  
 
DXA Lower total-body areal bone mineral density Z-
score in children with DM1 comparing to 
controls 
Heap et al. 2004 Cross-
sectional 
55 children with DM1 
and 95 reference (mean 
age 15yrs) 
pQCT/DXA Lower distal tibia trabecular bone density 
 
Lower femoral neck areal bone mineral density, 








42 children with DM1 
(mean age 14-15yrs) 
and 203 reference 
(mean age 15yrs) 
pQCT/DXA Lower tibia bone properties and strength, except 
higher tibia shaft cortical bone density in 
children with DM1 and lower increase on 
cortical bone mineral density at 12-month 
follow-up 
 
Lower total-body bone area and area bone 
mineral content, lumbar spine area, and areal 
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bone mineral content and density in children 
with DM1; lower increase on total-body bone 
area, and higher increase on lumbar spine bone 
area and areal bone mineral density at 12-month 
follow-up 
 
Higher muscle cross-sectional area at tibia shaft 
site at baseline, and higher increase at 12-month 






88 children and 
adolescents with DM1 
(mean age 11.7yrs) 
 
pQCT Lower total and cortical bone area at radius shaft 
in children with DM1 
 
Lower muscle cross-sectional area at radius shaft 
in children with DM1 
 
Saha et al. 2009 Cross-
sectional 
48 adolescents with 
DM1 (mean age 15yrs) 
and sex, age, height, 
weight and pubertal 
maturity matched 
control group (mean 
age 16yes) 
pQCT/DXA Lower distal tibia total bone mineral content and 
area, radius and tibia shaft total bone mineral 
content, cortical density and bone strength in 
participants with DM1 
 
Lower femoral neck and great trochanter areal 






27 children with DM1 
and 32 controls (mean 
age 10.5yrs) 
DXA No difference on total-body, lumbar spine, 
femoral neck and greater trochanter areal bone 
mineral density between children with and 








27 children with DM1 
and 32 controls (mean 
age 10.5yrs) 
DXA No difference on total-body, lumbar spine, 
femoral neck and greater trochanter areal bone 
mineral density between children with and 







54 adolescents and 
young adults with DM1 
(mean age 18yrs) and 
47 controls (mean age 
19yrs) 
 
pQCT Lower total bone area at distal radius in females 





95 children with DM1 
(mean age 10.5yrs) and 





Lower outer diameter, inner diameter, cortical 
area and medullary area at 2nd metacarpal in 





95 adolescents with 
DM1 (mean age 
16.6yrs) 
pQCT Lower trabecular bone mineral density at distal 
tibia, lower bone strength (SSIp) and cortical 
thickness at tibia shaft 
 
Chen et al. 2019 Cross-
sectional 
32 children with DM1 
and 27 controls (median 
age 14yrs) 
MRI/DXA Lower apparent bone volume to total volume, 
trabecular number and separation at proximal 
tibia in children with DM1 
 
Lower total and lumbar spine areal bone mineral 






85 children and 
adolescents with DM1 
(median age 13.2yrs) 
 
DXA Normal total body areal bone mineral density 
based on Z-score in adolescents with DM1 
Weber et al. 2019 Longitudinal, 
12-month 
follow-up 
32 children with DM1 
(mean age 14.2yrs) at 
baseline 
pQCT/DXA Lower trabecular and cortical bone mineral 
density at distal and shaft site tibia at baseline, 
respectively in children with DM1; lower 
trabecular bone mineral density at 12-month 





Lower total body less head areal bone mineral 
content and femoral head areal bone mineral 
density at baseline and follow-up in children 
with DM1; lower increase on femoral head areal 
bone mineral density over 12 months as well 
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1.3 Neuromuscular Performance 
Childhood muscle and bone growth and development are closely related to each other 
94,103,104. Muscle force is a surrogate of bone strength in children 105,106. However, maximal 
intrinsic muscle force cannot be assessed in live human 106. Previous studies have involved 
isokinetic maximal voluntary contraction tests, providing information like peak torque, as an 
indicator of maximal muscle force 106. Still, these movements cannot represent natural 
movements in daily life 107. Neuromuscular performance, often referred to as muscle function 
assessment, including multiple explosive movements, is not merely a muscle strength test. It 
provides information about not only the estimation of maximal muscle force but also motor 
performance and body coordination 108. I will introduce four different explosive movement 
complexes commonly used to test neuromuscular performance, including maximal push-up, grip 
force, and countermovement and long jump, to evaluate both upper and lower body muscle 
extremities. The maximal push-up is an upper body version of countermovement jump 108, and 
grip force measured by hand dynamometer is a widely used test for upper extremity 109,110. Jump 
is frequently used to assess children’s physical fitness at field settings, and its ground reaction 
force is also a predictor for tibia bone strength in children 111.  
 
1.3.1 Upper Extremities: Maximal Push-up and Grip Force 
The maximal push-up (MaxPU) is an explosive movement and also the upper body 
alternative of countermovement jump 108. Comparing to isometric contraction test, like grip 
force, push-up is a more complicated functional movement. The pushing action in push-up is 
related to daily life activities, like a horizontal version of pushing a box. Comparing to repetitive 
push-up to reach the upper body endurance limits, the maximal push-up is more focus on 
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maximal and explosive push-off force, represented by vertical ground reaction force, that 
participants can produce mainly from their upper body. There has been no study tested maximal 
push-up in children with DM1, but it was tested on youth athletes showing the push-off force is 
reliable in 10-15yrs old boys 112. Therefore, ground reaction force, the direct measure from the 
force platform, is used to characterize maximal push-up in children. 
Grip force (GF), measured by hand dynamometer, is a widely used isometric test to 
assess the upper extremity. Hand dynamometer measures hand grip in kilogram, which is later be 
converted into newtons to represent grip force. The hand dynamometer used in this study, Jamar 
dynamometer, has been reported with good reliability in children 113. Although handgrip is a 
simple isometric test, its force is an indicator of upper body muscle strength and distal radius 
bone strength in children 105,114. Overall, the grip force measure is a commonly-used and reliable 
upper extremity measure indicating both muscle and bone strength in children. Previous research 
provided various findings comparing grip strength in children with and without DM1. Fricke et 
al. suggested children with DM1 tended to develop lower grip force comparing to typically 
developing children 31, but Bechtold et al. reported participants with DM1 had higher grip 
strength comparing with reference data (Table 2) 13. Lukacs et al. reported only younger boys (8-
12yrs) with DM1 showed lower grip force (Table 2) 32.  
 
1.3.2 Lower Extremities: Jumps 
Jump mechanography, using the force platform to assess muscle function from dynamic 
movement, is a relatively new way to assess lower-body muscle extremity with better  
reproducibility and accuracy when compared to isokinetic maximal voluntary muscle contraction 
tests 106,109,115. Although grip force is a widely used and inexpensive test to estimate muscle 
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force, it can only evaluate maximal isometric contraction of upper body 109,110. 
Countermovement jump (CMJ) maximal take-off ground reaction force and power have been 
shown with good reproducibility in typically developing children 109. Also, countermovement 
jump force and power are indicators of lower leg muscle size and tibia bone strength in children 
and adults 30,106. Standing long jump (LJ) is a common school-based fitness test in children to 
measure musculoskeletal fitness 116, especially for jump length due to little equipment required. 
Jump length has been measured with good reliability in school-age children 116,117. However, 
although standing long jump is widely tested in children, force and related output, power and 
impulse, have been barely studied in standing long jump.  
There were only two studies comparing jump force in children with DM1. Both Fricke et 
al. and Maratova et al. reported adolescents with DM1 had normal maximal jump force and 
power comparing to reference data, but Maratova et al. also reported significantly lower maximal 
relative leg muscle force (maximal force/body mass) and power (maximal power/body mass) 
during countermovement jump (Table 2) 15,31. In addition, there was one study testing long jump 
length in children with DM1 (8-18yrs) but it did not report difference compared to controls 
(Table 2) 32. 
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Table 2: Summary of previous studies assessing neuromuscular performance on children or adolescents with DM1 
Author Year Study Design Participant Measurement Findings 
Bechtold et 
al. 
2007 Cross-sectional 88 children and 
adolescents with 
DM1 (mean age 
11.7yrs) 
 
Grip force Lower grip force comparing to reference 
data 
Fricke et al. 2008 Cross-sectional 40 children with 




jump ground reaction 
force and power 
 
Lower grip force, but no difference on 
countermovement jump force and power in 
children with DM1 comparing to reference 
data 
 
Lukacs et al. 2012 Cross-sectional 106 children and 
adolescent with 




Long jump length 
No difference on grip force and long jump 




2018 Cross-sectional 95 adolescents with 
DM1 (mean age 
16.6yrs) 
Countermovement 
jump ground reaction 
force and power 
No difference on countermovement jump 
force and power comparing to reference 
data, but lower relative force and power 
after divided by body mass or weight 
 29 
1.4 Muscle-Bone Interaction 
The theory of muscle-bone interaction between muscle loading and bone strength was 
derived from the “Mechanostat” model since muscle contraction would provide the largest load 
to the bones 43. Voluntary muscle contraction can produce up to 10 times of external loading on 
bones due to the short moment arm, which potentially helps stimulate bone adaptation 9,103,118. 
Especially in childhood, muscle and bone growth and development are closely related to each 
other 94,103,104. With increased loading from muscle or other external sources, bone has to 
withstand more strain, and, consequently, will become stronger to adapt to the strain 39,43,119.  
In terms of muscle-bone interaction between children with and without DM1, there is 
limited literature with discrepant findings assessing the relationship between muscle and bone 
outcomes in DM1 children. Moyer-Mileur et al. reported that adolescents with DM1 had higher 
muscle area but lower bone mineral content, as well as lower ToC/MuA ratio, which suggested 
bone properties might not adapt to muscle size (surrogate of muscle force/stimulus) as much as 
in typically developing children 17. On the other hand, Maratova did not report differences in 
muscle-bone interaction between DM1 adolescents and reference data 15.  
However, the role of muscle plays in bone outcomes is challenging to identify by just 
ratio or correlation. It is important to assess if muscle outcomes have a mediating role which 
explains possible bone difference in children and youth with and without DM1. This potentially 
supports future intervention aiming to improve muscle size and strength to optimize bone 
development in children with DM1.  
 
1.5 Summary and Research Gap 
The literature has reported that children with DM1 have higher fracture risk 2, but the 
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findings regarding bone and muscle in children with DM1 were disparate across studies. There 
are various tools that can image bone and muscle in children, but pQCT is a reasonable choice as 
it can measure bone geometry and density, and muscle size, as well as estimate bone strength at 
various sites of the radius and tibia 10,86. Neuromuscular performance, including maximal push-
up, grip force and jumps, are maximal and explosive tests that can assess upper and lower body 
muscle extremities 108–110. pQCT scans and neuromuscular performance can provide the 
opportunity to look into the potential difference in bone and muscle properties and strength for 
both upper and lower body limbs between children with and without DM1. 
One downside of previous studies involving pQCT was that they only measured one 
aspect over another (e.g., either bone or muscle, or either radius or tibia). This study would 
measure both bone and muscle properties and strength for both upper and lower body limbs 
using pQCT and neuromuscular performance in children with and without DM1. Additionally, 
the measurement of muscle also allows the exploration of the role of muscle size and force in the 
possible bone differences between DM1 and typically developing children, while previous 
studies only provided information on the relationship between bone and muscle characteristics in 
children with DM1. 
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2. Research Objectives, Questions and Hypotheses 
In order to explore the research gap, my thesis focused on the following two research 
objectives: 
 
2.1 Research Objective 1 
My first research objective is to assess the bone and muscle properties and strength 
difference between children with and without DM1.  
In order to address the first research objective, I asked the following research question: 
Do bone and muscle properties and strength differ between children with DM1 and typically 
develop children?  
I hypothesized bone and muscle properties and strength would differ between children 
with DM1 and typically developing children. 
 
2.2 Research Objective 2 
My second research objective is to explore the potential mediating role of muscle size 
and neuromuscular performance in explaining the differences in bone outcomes between 
children with and without DM1.  
In order to address the second research objective, I asked the following research question: 
Are muscle area and neuromuscular performance mediators explaining the differences in bone 
outcomes between children with and without DM1?  
I hypothesized muscle outcomes would be mediators explaining the bone differences 




3.1 Study Design and Participant Recruitment 
We recruited 38 children with DM1 from the local community, Saskatchewan diabetes 
camp (summer activity camp mainly for children with diabetes (age 6-15yrs) in Saskatchewan) 
and diabetes-related events for this cross-sectional investigation. A database of 170 typically 
developing children and youth, recruited from local schools and community programs,  served as 
controls 95. In my thesis analyses, I included 25 children with DM1 as the DM1 group and 168 
typically developing children as the control group. Participants included two groups were with 
valid peripheral quantitative computed tomography (pQCT) and neuromuscular performance test 
data (Figure 8). The age range for both groups was 6-15 years old, but participants in the DM1 
group were 1 years older and more mature, and 18% less physically active on average when 
compared to participants in the control group (Table 3).  
This study has been approved by University of Saskatchewan Biomedical Research 
Ethics Board. Parental consent and child assent were obtained prior to testing. 
 
Figure 8: Flowchart of DM1 and control group participants recruited and included in this study  
Total Recruitment 
N=208 (109 girls, 99 boys) 
Total recruitment for DM1 group
N=38 (21 girls, 17 boys)
25 scanned with pQCT  and force data tested in lab setting (BBAM)
(15 girls, 10 boys)
pQCT
24 distal radius scans
25 radius shaft scans
25 distal tibia scans
25 tibia shaft scans
1 distal radius 
scan excluded 
due to quality 
issue
Force
25 grip force measured
24 maximal push-up measured
25 countermovement jump measured
25 long jump measured
1 participant opt 
out maximal 
push-up
Total recruitment for control group 
N=170 (88 girls, 82 boys)
168 scanned with pQCT  and force data tested in lab setting (BBAM)
(88 girls, 82 boys)
pQCT
168 distal radius scans
161 radius shaft scans
169 distal tibia scans
165 tibia shaft scans
2 distal radius scans
9 radius shaft scans
1 distal tibia scans
5 tibia shaft scans
excluded due to 
quality issue
Force
168 grip force measured
163 maximal push-up measured
168 countermovement jump measured
168 long jump measured
1 participant opt out push-up only
1 participant opt out push-up and 
jump tests due to broken foot
5 maximal push-up force, 1 
countermovement and long jump 
force excluded due to force 
plate/processing error
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Table 3: Mean, standard deviation (SD) and difference of background characteristics in DM1 
and control groups. The significance of groups differences was set at p<.05. The significantly 
differed characteristics between groups were bolded. 
 
*Significance between groups tested with Mann-Whitney U test. The rest characteristics was 
tested with independent t-test 
 
3.2 Measurement Procedure 
3.2.1 Questionnaires 
There were three questionnaires in this study, “Physical Activity Questionnaire for 
Children”, “Limb Dominance, Medical History and Health Questionnaire” and “Food Frequency 
Questionnaire”. Participants and their parents/guardians had the choice to complete them before, 
during, or after the measurement session.  
Physical Activity Questionnaire for Children (PAQ-C) (Appendix 1) is a 7-day self-
reported recall of physical activity level for children. The questions include what sports 
participants play, physical activity at different time in a day, and potential barriers for physical 
activity. The focus of this questionnaire is the frequency and types of activity instead of 
intensity. PAQ-C has good validity and internal consistency reported in previous studies 120,121. 
The PAQ-C score is based on a 1 (low activity level) to 5 scale (high activity level) and was 
 DM1 Control  
Number 25 168  
 Mean SD Mean SD p-value 
Chronological Age (yrs) 12.3 2.2 10.8 1.8 0.001* 
Maturity Offset (yrs) -0.4 1.9 -1.5 1.6 0.002* 
Height (cm) 150.9 13.9 146.2 12.0 0.079 
Body Mass (kg) 48.0 17.7 40.7 12.7 0.042* 
PAQ-C 2.5 0.6 3.0 0.6 <0.001 
Protein (g) 75.0 36.5 66.0 34.9 0.100* 
Calcium (mg) 908.5 339.8 916.0 440.2 0.684* 
Vitamin D (IU) 135.6 98.3 191.7 162.1 0.174* 
Years after diagnosis 5.2 2.4    
HbA1c (%) 7.8 0.8    
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considered as a potential covariate in statistical analysis. 
Limb Dominance, Medical History and Health Questionnaire (Appendix 2) helped 
determine which limb/side to measure in pQCT and to analyze in neuromuscular performance 
testing. We typically measured the dominant limb; however, if children had previous fracture on 
their dominant limbs, their non-dominant limbs were measured instead. Medical history and 
health condition helped with the determination of participant eligibility. If there were any 
medication and diseases besides DM1 that participant had, which would influence bone and 
muscle health and growth, this child would be excluded from our study. This questionnaire also 
asked for DM1 durations, which is a confounding factor potentially influencing musculoskeletal 
growth and reported in background characteristic table 122.  
Food Frequency Questionnaire (Appendix 3) is a validated self-report dietary 
questionnaire to assess nutrition intake over past six months (NutritionQuest, 1998 BDDS) 123,124. 
It requires recall for a variety of food, including fruit, diary, cereal, vegetable, meat and fish, 
carbohydrates, as well as beverage and supplements. The finished questionnaires were then sent 
to NutritionQuest for dietary analysis to provide detailed information on calories and nutrient 
intake per day. 
 
3.2.2 Anthropometry Measurement  
Body height was measured in centimeters (cm) by a stadiometer on the wall (Holtain 
Limited, Crymych, UK), which can be accurate to the millimeter. When measuring height, 
participants stood straightly against the wall with shoes off and feet together. To measure seated 
height, participants sat on a box with back against stadiometer on the wall. The measurement 
was in centimeter scale and was then accurate to the millimeter. I subtracted the readings to box 
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height for seated height. Both body height and seated height were measured three times, and the 
median value was taken. Body mass was measured in kilogram (kg) by weight scale (Toledo 
Scale Company of Canada Ltd, Windsor, ON, Model 2830) to the nearest 0.5kg.  
 
3.2.3 Maturation Assessment 
The maturity status of participants was assessed by maturity offset (MO), which was the 
number of years at the measurement date away from the age of peak height velocity (aPHV). 
aPHV marks the age children will experience the highest rate of stature growth 125,126. MO is the 
estimated maturity in years calculated from sex-specific formulae considering both children’s 
chronological age and height or seated height 48, and the formulae are shown below (Equations 
3.1 & 3.2): 
Maturity	Offset	for	Boys = −8.128741 + 0.0070346	 × 	age	 × 	seated	height…………..(3.1) 
Maturity	Offset	for	Girls = −7.709133 + 0.0042232	 × 	age	 × 	height…………………..(3.2) 
Where the “age” is the participant’s chronological age (yrs). 
 
3.2.4 Medical Record Review 
I also reviewed the medical record to obtain the background characteristics of long-term 
blood glucose level and disease duration. Long-term blood glucose level was assessed by mean 
annual hemoglobin level (HbA1c, %). Disease duration in years was calculated by subtracting 
testing date and date of diagnosis. 
 
3.2.5 Bone and Muscle Properties Assessment  
Bone and muscle properties were measured from participant’s dominant forearm and 
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lower leg using the peripheral quantitative computed tomography (pQCT) (Stratec XCT 2000) 
with a slice thickness of 2.4mm and pixel size of 0.4mm*0.4mm 127. Previous studies reported 
the precision error of pQCT on children’s bone properties and strength measures (2-19%) 10 and 
adult muscle cross-sectional area (MuA) (1-4%) 128,129. Prior to testing, the participant’s forearm 
and lower leg length were measured. The forearm length was based on ulna length. During the 
measurement, participants were required to put their elbows on the table and to flex their elbows 
to make their dominant (or non-fractured) forearms perpendicular to the table. We took the 
measurement from the bottom of the elbow (olecranon process) to the most distal and lateral 
point of the styloid process of the radius using an anthropometric sliding caliper 10. The lower leg 
length was based on tibia length. Children sat on a chair with their ankle of the dominant (or 
non-fractured) leg on their thigh. Then, we measured the length from proximal border of the 
medial epicondyle to the most distal point of medial malleolus as lower leg length 10. The limb 
dominancy was determined by preferred writing hand and ball kicking foot for dominant arm and 
leg, respectively 10. After measuring limb length, we pre-scaned participants for scout view to 
determine the distal end of the ulna and tibia as a reference line, which was placed above the 
growth plate and distal to the proximal edge of epiphysis (Figure 9). pQCT took the scans at 4% 
and 65% sites of ulna from the most distal edge of the styloid process of ulna and 4% and 66% 
sites of the tibia from the most distal edge of the medial malleolus (Figure 10 & 11) 10. At distal 
sites, the threshold was set at 480mg/cm3 to separate cortical and trabecular bone, and 
200mg/cm3 to classify bone tissue. At shaft sites, the threshold was set at 480 mg/cm3 to separate 
cortical and trabecular bone, 280mg/cm3 to separate bones and soft tissues, and 40mg/cm3 to 
separate muscle and subcutaneous fat 10,93,94. At distal sites, total bone properties (content (ToC, 
mg/mm) density (ToD, mg/cm3) and area (ToA, mm2)) and trabecular bone properties (content 
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(TrC, mg/mm), density (TrD, mg/cm3) and area (TrA, mm2),) were measured. At shaft sites, total 
bone properties (content (ToC) density (ToD) and area (ToA)) and cortical bone properties 
(content (CoC, mg/mm), density (CoD, mg/cm3) and area (CoA, mm2)) were measured. The 
precision errors of bone properties range from 2-19% for distal sites, and 2-8% for shaft sites in 
our lab 10. Participants were required to keep still during the whole scan to achieve the best 
quality of the scan images. Unlike bone properties, muscle property, and muscle cross-sectional 
area (MuA, cm2) was only measured at shaft sites. The unpublished precision errors of MuA 
from our lab range from 3-4%.  
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Figure 9: Sample reference line placement for radius (a,b) and tibia (c,d) from scout view scans 
during pQCT scan. Adapted from Duff et al. (2017) 10 
 
 
Figure 10: One participant was receiving arm (left) and leg (right) scans with pQCT  
 
Figure 11: Sample lower leg (left) and forearm (right) scans at distal and shaft sites with pQCT 
 
3.2.6 Bone Strength Estimation 
Bone strength was determined by bone strength index for compression (BSIc, mg2/cm4) at 
distal sites and density-weighed section modulus (SSIp, mm3) at shaft sites. BSIc and SSIp were 
calculated by the following equations (Equations 3.3 & 3.4) 28,91: 









Where a represents the cross-section area of one voxel (mm2), d is the distance from the voxel to 
center of gravity (mm), and dYLZ is the distance from the farthest voxel to the center of gravity 
(mm). CoD is the cortical bone density (mg/mm3) at the shaft, and ND is the normal 
physiological density (mg/mm3) 28.  
The bone strength index for compression (BSIc) is able to explain 85% of the variance in 
bone failure load at the distal site based on validation study, and had a precision error of 8% in 
children from our lab 10,91. Density-weighed polar sectional modulus (SSIp) considers not only 
the bone density but also the bone size and material distribution to assess the ability that bone 
resists torsional loading at the radial and tibial shaft 91. The precision error for SSIp is 6% in 
children from our lab 10. Therefore, BSIc and SSIp were used to represent bone strength in this 
study. 
 
3.2.7 Neuromuscular Performance  
Maximal Push-up (MaxPU) is an upper-body explosive test, which requires participants 
to push themselves off from the ground as high as possible without bending elbows after hands 
leaving the ground until reaching the top of the movement 108. Before performing MaxPU, 
participants were required to place their hands shoulder-width apart on two force platforms 
(Figure 12 A). During the test, participants started from a full plank position and elbow fully 
extended. Then they lowered down their bodies by bending the elbows. After the elbows ware 
bent at least 90 degrees or reached their limit, participants pushed their bodies up as fast as they 
could. The highest ground reaction force during push-off phase was selected based on kinematic 
data collected by an eight-camera motion capture system (Vicon Nexus, Vicon Motion Systems, 
CO) and then processed by Matlab code (R2006b). Reflective tracking markers were placed on 
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participants’ two shoulder joints (acromioclavicular joints) and on the top of their backs 
(centered between superior scapulae) prior to the testing. These three markers could help capture 
vertical movement of upper body. The maximal push-off ground reaction force was selected 
during the “upward” phase of the push-up. Three trials were performed, and the largest push-off 
ground reaction force (Newton, N) from the dominant arm among all three trials was used for 
statistical analysis. The unpublished precision error of MaxPU force is 9% in our lab. 
Maximal Grip Force (GF) is a common test to assess children’s hand and wrist strength, 
which was measured by JAMAR 200 hand dynamometer (Sammon Preston Inc., Boldingbrook, 
IL) (Figure 12 B) in kilogram and then converted into Newton. While lab technician was saying 
“Squeeze as hard as you can. Squeeze. Squeeze. Squeeze”, participants squeezed the hand 
dynamometer as hard as they could with elbow flexing 90 degrees and arm away from the body 
113. Participants performed this test three times on each hand with alternating hands to eliminate 
the potential muscle fatigue. Only the maximal force (N) from the dominant hand, one 
representation of upper body muscle force, was recorded for further analysis. The unpublished 
precision error of GF is 14% in our lab. 
Countermovement Jump (CMJ) is an explosive jumping test to assess children’s lower 
body muscle extremity. Participants started by standing upright on one force platform, then 
performed a countermovement by jumping as high as they could (Figure 12 C). Arm swing was 
allowed during the movement. Knee angles during countermovement and jumping were not 
specifically controlled. This test involved three trials. The maximal vertical ground reaction force 
(N), power (Watts, W) and impulse (Newton second, Ns) during take-off phase were measured 
for each trial to represent lower body muscle force. Only the data from the trial with the highest 
impulse was used for further statistical analysis. The unpublished precision errors of CMJ 
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outcomes range from 11-23% in children in our lab. 
Long Jump (LJ) is the other explosive jumping test to assess children’s lower extremity. 
Participants started from standing on one force platform behind a marked take-off line, then 
jumped as far as they could (Figure 12 D,E). The LJ length was measured from the take-off line 
to the back of the participants’ heel closest to the take-off line. Arm swing was allowed during 
the movement. Knee angle before and during the jump was not specifically controlled, either. 
This test was performed three times. The maximal vertical and horizontal ground reaction force, 
power and impulse and jumping length (cm) were measured for each trial during take-off phase 
to represent lower body muscle force, but only values from the trial with the longest jumping 
length was used for further statistical analysis. The unpublished precision errors of LJ outcomes 
range from 6-25% in children in our lab. 
 
Figure 12: Neuromuscular performance tests in biomechanics lab: A) Maximal Pushup force 
was measured based on two force platforms. B) Maximal grip strength was measured by a 
handgrip dynamometer. C) Maximal countermovement jump force was measured on the single 
force platform. D,E) Maximal Long jump horizontal and vertical force was measured based on 
the single force platform.  
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3.3 Statistical Analysis 
I separated measurement into two sets of outcomes, bone and muscle outcomes. I 
analyzed radius, tibia, upper body, and lower body muscle outcomes separately. Upper-body 
muscle outcomes included forearm muscle area, grip force and maximal push-up force. Lower 
body muscle outcomes included lower leg muscle area and countermovement and long jump 
outcomes. Both sexes were combined in the analyses.  
 
3.3.1 MANCOVA Assumptions  
Bone Outcomes: I checked (1) the normality of all pQCT outcomes in both DM1 and 
control groups by visual inspection with normal Q-Q plots, (2) independence of observation with 
Durbin-Watson test, which all values were close to 2, (3) outliers with boxplots, and there were 
two outliers for distal radius total bone density (ToD) and one for tibia shaft cortical content 
(CoC) in control group. However, I retained the outliers in statistical analysis since exclusion did 
not influence my results. I also checked (4) homogeneity of variance and covariance matrices by 
Levene’s test (p<.05) and Box’s test (p<.001), respectively. Homogeneity of regression 
coefficients was checked by scatter plots. There was significance on the homogeneity of variance 
on distal radius total bone content (ToC), trabecular content (TrC), and radius shaft cortical 
content (CoC), tibia shaft total bone area (ToA). Also, there was violation on homogeneity of 
covariance in both radius and tibia. I checked (5) linearity between all pairs of dependent 
variables (DVs, bone outcomes) and independent variable (IV, diabetes status), and DVs and 
covariates using scatter plots. (6) Multicollinearity and singularity in between DVs and IV were 
checked by VIF (<10) or tolerance (>0.1) values and bivariate correlation (r < 0.9), respectively.  
 43 
Muscle Outcomes: I checked (1) the normality of all force and related outputs in both 
DM1 and control groups by visual inspection with normal Q-Q plots, (2) independence of 
observation with Durbin-Watson test, which all values were close to 2, (3) outliers with boxplots. 
There were two outliers for forearm muscle area (MuA) and one for lower leg MuA, one for 
countermovement jump vertical impulse and one for long jump horizontal impulse in the control 
group. However, I retained the outliers in statistical analysis since exclusion did not influence my 
results. I also checked (4) homogeneity of variance and covariance matrices by Levene’s test 
(p<.05) and Box’s test (p<.001), respectively. Homogeneity of regression coefficients was 
checked by scatter plots. There was significance on homogeneity of variance on maximal push-
up ground reaction force and countermovement jump vertical power and long jump vertical 
force. Also, there was violation on the homogeneity of covariance in upper body muscle 
outcomes. I checked (5) linearity between all pairs of dependent variables (DVs, muscle 
outcomes) and independent variable (IV, diabetes status), and DVs and covariates using scatter 
plots. (6) Multicollinearity and singularity in between DVs and IV were checked by VIF (<10) or 
tolerance (>0.1) values and bivariate correlation (r < 0.9), respectively. 
In the case of assumption violation, I transformed all bone and muscle outcomes, height, 
body mass, PAQ-C score and nutrition intake, based on lg10 algorithm, and then ran the 
transformed variables in MANCOVA again for the same models. The same covariates stayed for 
each MANCOVA model but in the transformed form, except for maturity offset. I included the 
results after data transformation Appendices 4 and 5 (Table 6 & 7). However, I still reported the 
results and discussed the findings based on the data before transformation, since they are easier 
for interpretation and the results are comparable before and after transformation. 
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3.3.2 Covariate Determination 
The potential covariates were sex, maturity offset, height, body mass, PAQ-C score and 
nutrition factors (calcium, vitamin D and protein) for bone and muscle outcomes 47,49–52,54–56,61,64–
67. I first determined if any of the potential covariates differed between the groups using either 
independent t-test or Mann-Whitney U test depending on the normality of distribution for each 
factor in both control and DM1 groups (p<.05). The sex difference between groups was tested 
using chi-square (p<.05). Maturity offset, body mass and PAQ-C score differed between groups; 
hence they were applied into MANCOVA model. However, PAQ-C score only contributed to 
the model for lower body muscle outcomes, determined by the significance of multivariate 
significance (p<.05) in the model (p<.05). Therefore, for radius and tibia bone outcomes and 
upper body muscle outcomes, the covariates I selected were maturity offset and body mass for 
the MANCOVA models to test hypothesis 1. For lower body muscle outcomes, the covariates 
were maturity offset, body mass and PAQ-C score.  
 
3.3.3 Mediation 
Mediation is a hypothesis that one factor could intermediate during the process which one 
variable affects another variable, which the factor is usually labeled in “M” as mediator (Figure 
13) 130. The independent variable is labeled as “X”, and the dependent variable is labeled as “Y” 
(Figure 13) 130. The amount of mediation is referred to “indirect effect” 130. Pathway c in Figure 
13 is “total effect” and c’ is “direct effect”, which total effect is the sum of direct and indirect 
effect 130. Pathway a and b are both “direct effect” from X to M and M to Y, respectively (Figure 
13) 130. The “indirect effect” can be calculated by c subtracting c’ 130. The “effects” are 
characterized by the unstandardized beta coefficient in each regression model 130. 
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Figure 13: Diagram showing total effect (c) between an independent variable (X) and dependent 
variable (Y) (upper figure), and direct effect (a, b, c’) from X to M, M to Y and X to Y without 
M, respectively 
 
The analysis of mediation is usually based on regression analysis with a four-step 
analysis 131. The first step is to test the relationship between X and Y as pathway c, followed by 
testing the relationship between X and M, as pathway a, and M and Y, as pathway b, by bivariate 
regression 131. The last step is to run a multiple regression including both X and M predicting Y 
as pathway c’ 131. The popular method to evaluate mediation is by using bootstrap 130, since 
bootstrap does not require the assumption of normality and works for small to large sample sizes  
130,132,133. The independent variable (X), DM1 and control groups, in this study was binary and 
not continuous. Therefore, bootstrapping is an ideal choice when exploring mediation in this 
study. Bootstrapping assumes a non-parametric way relying on random resampling with 
replacement for a large number of times, like 5000 times 130. Bootstrapping provides a 
confidence interval for calculating indirect effect; a confidence interval without crossing zero 
implies the significance of mediation, or indirect effect 130.  
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3.3.3 Hypothesis Testing: Research Objective 1 and 2 
Objective 1: I used multiple analysis of covariance (MANCOVA) to determine if there 
was a significant difference in bone outcomes, including radius and tibia properties and strength, 
and upper and lower body muscle outcomes between groups (p<.05). The corresponding 
covariates I adjusted in MANCOVA models were maturity and body mass for radius, tibia and 
upper body muscle outcomes, and maturity, body mass and PAQ-C score for lower body muscle 
outcomes. I reported the omnibus effect in each bone or muscle MANCOVA model. I also 
reported the mean and standard deviations of each outcome for both groups, as well as between-
group adjusted mean differences and % difference with 95% confidence interval. 
Objective 2: I tested mediation using macro code for SPSS (PROCESS, Hayes, 2018) by 
adding MuA or neuromuscular performance outcomes as a possible mediator one by one into the 
regression models. In the models, I included groups as X and differed bone outcomes between 
groups determined in Objective 1 as Y as well as the same covariates, maturity and body mass. 
Significance of mediation was determined by 95% confidence interval of indirect effect 




4.1 Research Objective 1: Bone and Muscle Outcomes 
4.1.1 Radius 
There was a significant group difference (omnibus effect) in radius bone outcomes, 
F(12,168) = 4.705, p<.001. At the distal radius, there were no significant differences in bone 
properties and strength between DM1 and control groups (Table 4). At radius shaft sites, there 
were 8% higher cortical bone density (CoD) and 7% lower cortical bone area (CoA) in DM1 
group (Figure 14, Table 4). None of the other radius shaft bone properties nor strength 
parameters differed between groups (Table 4). 
 
 
Figure 14: Bar graph showing adjusted mean % difference of radius properties and strength with 




There was a significant group difference (omnibus effect) in tibia bone outcomes, 
F(12,173) = 3.881, p<.001. At distal tibia, there was no significant difference between DM1 and 
control groups on bone properties and strength (Table 4). At the tibia shaft, children with DM1 
had 6% lower cortical bone area content (CoC), 5% higher cortical bone density (CoD) and 10% 
lower cortical bone area (CoA) (Figure 15, Table 4). The rest of tibia shaft bone properties and 
strength parameters did not have significant difference between groups (Table 4). 
 
Figure 15: Bar graph showing adjusted mean % difference of tibia properties and strength with 
95% confidence intervals comparing DM1 group with the control group 
 
Table 4: Mean, standard deviation (SD), adjusted mean difference and % difference of bone 
properties and strength between DM1 and control groups. The significance of groups differences 





4.1.3 Muscle Area and Neuromuscular Performance 
There were significant group differences (omnibus effect) in upper (F(3,172) = 3.111, p= 
.028) and lower body (F(11,125) = 2.100, p=.025) muscle outcomes. Participants in DM1 group 
had higher maximal push-up group reaction force (12%) compared to control group (Figure 16 & 
 DM1 Control    
 Mean SD Mean SD p-value Difference % Difference 
Distal Radius        
  ToC (mg/mm) 76.0 14.4 73.7 14.0 0.470 2.3 3.1 
  ToD (mg/cm3) 285.2 36.3 288.6 35.3 0.668 -3.4 -1.2 
  ToA (mm2) 262.8 45.0 256.9 43.7 0.555 5.9 2.3 
  TrC (mg/mm) 59.8 14.7 58.9 14.3 0.784 0.9 1.5 
  TrD (mg/cm3) 248.3 26.1 253.5 25.4 0.366 -5.2 -2.1 
  TrA (mm2) 236.3 49.7 232.3 48.3 0.712 4.0 1.7 
  BSIc (mg2/mm4) 22.2 6.1 21.5 5.9 0.596 0.7 3.3 
Radius Shaft        
  ToA (mm2) 121.9 23.4 127.6 22.7 0.268 -5.7 -4.5 
  CoC (mg/mm) 68.2 10.1 67.2 9.8 0.664 1.0 1.4 
  CoD (mg/cm3) 903.8 70.5 836.5 68.6 <0.001 67.3 8.1 
  CoA (mm2) 74.5 10.7 80.2 10.4 0.016 -5.7 -7.1 
  SSIp (mm3) 211.6 42.5 198.3 41.4 0.156 13.3 6.7 
Distal Tibia        
  ToC (mg/mm) 211.7 35.2 218.4 34.4 0.375 -6.7 -3.1 
  ToD (mg/cm3) 284.0 31.5 288.9 30.9 0.473 -4.9 -1.7 
  ToA (mm2) 741.8 120.0 759.2 117.3 0.503 -17.3 -2.3 
  TrC (mg/mm) 164.8 36.6 171.7 35.8 0.381 -6.9 -4.0 
  TrD (mg/cm3) 245.6 23.6 249.8 23.1 0.411 -4.2 -1.7 
  TrA (mm2) 669.5 130.9 685.4 128.1 0.572 -16.0 -2.3 
  BSIc (mg2/mm4) 61.1 14.6 63.6 14.3 0.427 -2.5 -4.0 
Tibia Shaft        
  ToA (mm2) 476.4 73.9 497.3 72.3 0.191 -20.9 -4.2 
  CoC (mg/mm) 224.3 30.0 238.2 29.3 0.033 -13.9 -5.8 
  CoD (mg/cm3) 932.9 49.9 892.3 48.8 <0.001 40.6 4.6 
  CoA (mm2) 238.8 33.6 266.2 32.9 <0.001 -27.4 -10.3 
  SSIp (mm3) 1466.1 265.8 1503.6 260.1 0.513 -37.6 -2.5 
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17, Table 5). There were no differences between the groups in forearm and lower leg muscle 
cross-sectional area, grip force and all jump outcomes (Table 5).  
 
Figure 16: Bar graph showing adjusted mean % difference of upper body muscle outcomes with 
95% confidence intervals comparing DM1 group to the control group 
 
 
Figure 17: Bar graph showing adjusted mean % difference of lower body muscle outcomes with 
95% confidence intervals comparing DM1 group to control group
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Table 5: Mean, standard deviation (SD), adjusted mean difference and % difference of muscle area and neuromuscular performance 
outcomes between DM1 and control groups. The significance of groups differences was set at p<.05. The significant different muscle 

























 DM1 Control    
 Mean SD Mean SD p-value Difference % Difference 
Upper Body        
Forearm MuA (cm2) 22.6 3.0 22.1 2.9 0.462 0.5 2.2 
Maximal Grip Force (N) 201.2 39.3 188.0 38.6 0.128 13.2 7.1 
Maximal Push-up Force (N) 203.2 32.3 182.2 31.7 0.004 20.9 11.5 
Lower Body        
Lower Leg MuA (cm2) 41.6 5.7 43.3 5.3 0.227 -1.7 -3.9 
Countermovement Jump        
  Vertical Force (N) 831.4 110.3 880.5 103.6 0.071 -49.1 -5.6 
  Vertical Power (W) 1626.6 385.4 1772.1 362.0 0.125 -145.5 -8.2 
  Vertical Impulse (Ns) 90.8 16.1 92.9 15.1 0.591 -2.1 -2.3 
Long Jump        
  Vertical Force (N) 846.4 101.9 832.5 95.7 0.577 13.9 1.7 
  Horizontal Force (N) 308.7 56.7 287.2 53.2 0.122 21.6 7.5 
  Vertical Power (W) 993.4 246.8 1054.3 231.9 0.314 -60.9 -5.8 
  Horizontal Power (W) 564.4 183.0 522.3 171.9 0.348 42.1 8.1 
  Vertical Impulse (Ns) 55.8 12.6 57.7 11.9 0.535 -1.9 -3.3 
  Horizontal Impulse (Ns) 90.6 13.4 85.9 12.6 0.154 4.7 5.5 
  Length (cm) 137.9 23.4 134.5 22.0 0.549 3.4 2.6 
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4.2 Research Objective 2: Mediation of Muscle Outcomes on Bone Outcomes 
Lower leg muscle area was a mediator in predicting the tibia shaft cortical bone content 
(indirect effect = -5.1, 95%CI = -10.76, -0.03) and area (indirect effect = -5.5, 95%CI = -11.82, -
0.00) differences between DM1 and control groups (Figure 18 & 19), as the 95% confidence 
interval (CI) of indirect effect does not cross zero. Other muscle outcomes did not have 
significant indirect effect due to the 95% CI across zero.  
 
Figure 18: Pathway diagram showing group (X) predicting tibia shaft CoC (Y) without 
considering possible mediator (M) lower leg MuA (pathway c), and with considering lower leg 
MuA as mediator (pathway c’). Pathway a represents the group (X) predicting mediator, lower 
leg MuA (M). Pathway b represents the mediator, lower leg MuA (M), predicting tibia shaft CoC 
(Y). Unstandardized beta (!) and significance of prediction of individual pathway and covariates 
(p<.05), as well as the indirect effect of the mediator, lower leg MuA, and its 95% confidence 






Figure 19: Pathway diagram showing group (X) predicting tibia shaft CoA (Y) without 
considering possible mediator (M) lower leg MuA (pathway c), and with considering lower leg 
MuA as mediator (pathway c’). Pathway a represents the group (X) predicting mediator, lower 
leg MuA (M). Pathway b represents the mediator, lower leg MuA (M), predicting tibia shaft CoA 
(Y). Unstandardized beta (!) and significance of prediction of individual pathway and covariates 







5. Discussion  
My findings suggested group difference in bone and muscle outcomes between children 
with DM1 and their typically developing peers. Children in DM1 group had 7% lower cortical 
bone mineral area, and 8% higher density at the radius shaft. My thesis findings added evidence 
to previous literature measuring radius with pQCT, in which children with DM1 had lower shaft-
site cortical bone area 12,13. I did not detect between-group difference in radius shaft SSIp while 
Saha et al. reported 5-9% lower radius shaft SSIp in children with DM1 12. However, there was 
no difference at the distal radius between the DM1 and control groups, which agreed with two 
previous studies with radius measurement 12,13.  
For tibia, we observed 6% and 10% lower shaft-site cortical bone content and area, 
respectively, and 5% higher cortical bone density, which supported previous findings 17. 
However, we did not find any difference at distal tibia outcomes and tibia shaft bone strength 
(SSIp), which contrasted with the previous literature reporting 5-10% lower trabecular bone 
outcomes 15,17 and 9-12% lower SSIp 12,15. Our findings on the tibia were similar to the radius, 
both suggesting lower cortical bone area and higher density at both upper and lower body limbs. 
Furthermore, although there was no difference found at distal sites of the radius and tibia, it did 
not represent there was no difference if looking into bone micro-structure.  
For muscle size, there was no difference in muscle cross-sectional area between groups in 
our study. In terms of previous literature, Bechtold et al. reported 0.2-0.3 standard deviation 
below the mean of German reference population on forearm muscle cross-sectional area 13, and 
Moyer-Mileur reported 1% higher at lower leg muscle area comparing to their non-diabetic 
control group 17. The findings on muscle size seemed inconsistent. However, muscle area did not 
appear to have big difference between children with and without DM1 even if the difference was 
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significant, since the observed change was smaller than the unpublished precision error of pQCT 
measured muscle area (3-4%) from our lab.  
The children with DM1 had an average HbA1c of 7.8% , which suggested a good 
glycemic control when compared to previous literature with values ranging from 8.2 to 9.2% 
12,15,17. Our findings on cortical bone area and distal radius were comparable one previous paper 
with similar average HbA1c level (7.7%), but they also reported lower total bone area and 
muscle cross-sectional area at radius shaft as well as higher grip strength 13. There was a study 
comparing the pQCT results between children with good (<7.5%) and poor (≥7.5%) glycemic 
control, and reported the gains in distal tibia trabecular bone density and tibia shaft total and 
cortical bone area were less in children with poor glycemic control when compared to those 
children with good glycemic control 14. However, even if the growth differed after 12 months, 
they did not report differences in tibia shaft total and cortical bone area between children with 
good and poor glycemic control and between children with DM1 and reference 14. Therefore, the 
glycemic control may play a role on bone outcomes, but more evidence is needed before 
determining the exact role of glycemic control in bone and muscle development.  
For nutrition intake, only Moyer-Mileur et al. reported calcium intake in children with 
DM1 17. Participants in their study appeared to have higher daily calcium intake in both DM1 
and reference groups comparing to ours, and there was no group difference in calcium intake 17. 
Their findings at tibia shaft matched with our findings, but they also reported lower trabecular 
bone area, density and content at distal tibia and lower leg muscle area 17. However, the disparate 
findings on distal-site bone outcomes and muscle area between their and our studies cannot be 
explained by calcium intake, since calcium intake did not differ between groups in these two 
studies.  
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In terms of neuromuscular performance, maximal push-up force was 12% greater in 
children with DM1. The potential explanation for higher MaxPU force in children with DM1 
was the greater relative number of children (data not shown) participating in sports including 
upper body training,  like gymnastics and taekwondo 134,135. We did not observe differences in 
grip force which agreed with a previous study 31 but disagrees with others 12,27. We did not 
observe differences in jump force and power, and long jump length between the groups, which 
agreed with previous literature suggesting normal jump take-off force and power in children with 
DM1 when compared to reference values based on z-scores 15,31.  
In terms of the mediation role of muscle, our findings suggested lower leg muscle area as 
a mediator in between the relationship of DM1 status and tibia shaft cortical bone area and 
content. The calculated “indirect effect” implied that the between-group difference in cortical 
area and content might be lower by increasing muscle size at the lower leg in children with DM1. 
There was no previous literature assessing the role of muscle in bone outcomes in DM1 children. 
Other muscle outcomes, like neuromuscular performance, were not significant when testing for 
mediation. However, some of them might still be mediators with a larger sample size as the 
boundaries of 95% CI of some neuromuscular performance outcomes were close to zero. Also, 
neuromuscular performance testing appeared to have larger precision errors (6-25%) than muscle 
area (3-4%) based on unpublished precision error from our lab. As a result, a larger sample size 
might be required to detect its role as a possible mediator.   
 
5.1 Clinical relevance  
These findings provided evidence that children with DM1 had lower bone cortical bone 
area but higher density at both radius and tibia shaft, and lower cortical bone content at tibia 
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shaft compared to typically developing children. Although the bone strength did not differ 
between groups, the smaller but denser cortical bone at shaft sites may suggest a lower bone 
turnover rate in children with DM1 during growth 18,19,83. During growth, the bone grows in 
length, and the trabeculae close to the periosteal surface will thicken and develop into cortical 
bone 136. The cortical bone formation cannot match the speed of resorption during rapid growth, 
which is likely to leave more pores inside the cortical bone and reduces the cortical bone density 
136. However, when the bone turnover rate or bone formation is lower, the cortical bone may not 
form as much as in typically developing children, and there would not be as much porosity as 
well 136. Therefore, the potential lower bone turnover might be the reason underlying both the 
higher cortical bone density and smaller cortical bone area. This is clinically important because it 
may relate to the development of weaker skeleton in the future, and contribute to the reported 
higher fracture risk in individuals with DM1 2,106.  
Our findings also suggest if children with DM1 have larger lower leg muscle size, the 
difference in tibia shaft cortical area and content between children with and without DM1 might 
be smaller. An intervention focusing on enlarging lower body muscle size might be beneficial for 
developing larger size cortical bone at tibia shaft in children with DM1. High impact exercise, 
like jumps, might be an ideal choice of exercise improving muscle size, and also jumps can help 
improve bone strength in children 20,63. 
 
5.2 Strengths and Limitations 
This study had a few strengths and limitations that warranted discussion. The first 
strength related to the bone imaging tool, pQCT, which facilitated the investigation of bone and 
muscle in children with and without DM1. pQCT allowed me to separate cortical and trabecular 
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bone and to measure their size and “true” volumetric bone mineral density. Furthermore, the 
study design involved an actual control group instead of comparing to reference data like some 
of the previous studies 13–15. The control group data was also collected from our lab with the 
same measurement tools and procedures within the same lab space with known measurement 
precision errors. In addition, we also evaluated muscle size and force produced in neuromuscular 
performance to assess how strong the muscle is. Muscle cross-sectional area was a relatively 
precise way and good surrogate of muscle strength 92. Neuromuscular performance had a focus 
on maximizing muscle force output in a more direct way, and was measured from movements 
involving motor performance and body coordination 108. Previous studies usually only focused 
on one way or another. In this way, we were able to assess the role of both muscle size and force 
in bone properties and strength in children with and without DM1.  
There are also some limitations in this study. Firstly, there was a relatively small sample 
size in DM1 group and the uneven sample size between two groups; if there would be more 
participants in DM1 group, the power of analysis would be stronger 137. Secondly, we were not 
able to obtain PAQ-C score (133 in control group, 20 in DM1 group) and nutrition data (103 in 
control group, 23 in DM1 group) from all participants, which reduced our sample size in both 
groups and the power during analysis when including PAQ-C score as a covariate. Thirdly, there 
were limitations related to the voluntary muscle contraction during the neuromuscular 
performance test, which could be influenced by skill level as well as motivation, like how hard 
they wanted to push themselves, at the testing day 109,138. The skill level was not controlled since 
most of these tests were commonly used in general children 110,139. Although the practice trials 
were provided and checked by researchers, the skill level nor motivation was not recorded and 
thus not addressed in the analyses. As a result, neuromuscular performance appeared to be higher 
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in precision error and had more variability during testing comparing to muscle area obtained 
from pQCT scans. 
 
5.3 Future Directions 
A larger sample of children with DM1 is required for the future for a sex-specific 
analysis. Matching sex, maturity, height and body mass between the DM1 and control groups 
would be ideal for identifying disease influence on bone and muscle. Another direction could be 
exploring growth in children with DM1, by one-year or longitudinal follow-up, and then 
comparing bone and muscle growth with typically developing children. Follow-up study will be 
meaningful to see if bone growth and development in children with DM1 differs from children 
without DM1, owning to suspicion of the altered bone turnover rate in children with DM1 
19,27,84,140. Also, there is no previous study linking bone formation and resorption biomarkers to 
long bone growth in geometry, properties and strength in children with DM1, which makes it a 
meaningful direction to be explored. Bone formation and resorption biomarkers could be 
measured along with bone scans in a longitudinal study to monitor the long-term change in bone 
turnover, which would help build a potential linkage between biomarkers and bone strength. In 
addition, future research could include subgroup analysis taking disease duration into 
consideration when analyzing bone properties and strength in children with DM1, since a 
previous study suggested an early manifestation could alter bone growth 13.  
In this study, we suggested muscle area could mediate and explain the cortical bone 
content and area difference between groups. A future study could look into the relationship 
between muscle and bone in children with DM1 in a clinical way through a “functional muscle-
bone unit”. This is an analysis of bone properties with consideration of muscle function, which 
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was developed for clinical assessment of the bone deficits for individual children 33,35. It could be 




There was group difference (omnibus effect) in bone and muscle outcomes between 
children with and without DM1. Children with DM1 had 7-10% lower cortical bone area and 5-
8% higher density at the radial and tibial shaft, and 6% lower cortical bone content at the tibial 
shaft compared to typically developing children. Children with DM1 also produced 12% higher 
maximal push-up force when comparing to their typically developing peers. Lower leg muscle 
area was a mediator explaining the tibia shaft cortical bone area and content difference between 
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Appendix 1 Physical Activity Questionnaire for Children (PAQ-C) 
 
 Physical Activity Questionnaire  
For Bone Strength Study 
 
Name__________________        Age________ 
 
Sex  M______   F______         
 
 
We are trying to find out about your level of physical activity from the last 7 days (in the last week). This 
includes sports or dance that make you sweat or make your legs feel tired, or games that make you breathe hard, 
like tag, skipping, running, climbing, and others.  
  
Remember:  
There are no right and wrong answers — this is not a test.  
Please answer all the questions as honestly and accurately as you can — this is very important.  
 
1. Physical activity in your spare time: Have you done any of the following activities in the past 7 days 





Rowing/canoeing ................................     
In-line skating .....................................     
Tag ......................................................     
Walking for exercise ...........................      
Bicycling .............................................      
Jogging or running ...............................      
Aerobics ..............................................      
Swimming ............................................      
Baseball, softball .................................      
Dance ..................................................      
Football ...............................................      
Badminton ...........................................      
Skateboarding ......................................      
Soccer ....................................………..      
Street hockey .......................................      
Volleyball ............................................      
Floor hockey .......................................      
Basketball ............................................      
Ice skating ............................................      
Cross-country skiing ............................      




Other:  _________________________ 
_________________________      
  
 
   No      1-2      3-4      5-6      7 or  















































































































































2. In the last 7 days, during your physical education (PE) classes, how often were you very active 
(playing hard, running, jumping, throwing)? (Check one only.)  
I don’t do PE .....................................................…... 
Hardly ever ..............................................................   
Sometimes ...............................................................  
Quite often ............................................................... 
Always .....................................................................   
   
3. In the last 7 days, when you were active, how often did you use your hands for pushing, climbing, 
or throwing? (Check only one.) 
  I only use my legs ................................................... 
Hardly ever................... ............................................   
Sometimes ................................................................  
Quite often ................................................................ 
Always .....................................................................   
 
4. In the last 7 days, what did you normally do at lunch (besides eating lunch)? (Check one only.)  
  
Sat down (talking, reading, doing schoolwork).….... 
Stood around or walked around ...............................   
Ran or played a little bit ..........................................   
Ran around and played quite a bit ...........................   
Ran and played hard most of the time .....................   
   
5. In the last 7 days, on how many days right after school, did you do sports, dance, or play games in 
which you were very active? (Check one only.)  
None .................................................................…. 
1 time last week .....................................................  
2 or 3 times last week ............................................  
4 times last week ...................................................   
5 times last week .................................................... 
  
6. In the last 7 days, on how many evenings did you do sports, dance, or play games in which you were 
very active? (Check one only.)  
   None ........................................................................   
1 time last week .......................................................   
2 or 3 times last week ..............................................   
4 or 5 last week ........................................................   
6 or 7 times last week ..............................................   
  
7. On the last weekend, how many times did you do sports, dance, or play games in which you were 
very active? (Check one only.)  
None ........................................................................   
1 time .......................................................................   
2 — 3 times .............................................................   
4 — 5 times .............................................................   


































8. Which one of the following describes you best for the last 7 days?  Read all five statements before 
deciding on the one answer that describes you.  
  
F. All or most of my free time was spent doing things that involve little  
physical effort  
  
G. I sometimes (1 — 2 times last week) did physical things in my free time 
(e.g. played sports, went running, swimming, bike riding, did aerobics)  
  
H. I often (3 — 4 times last week) did physical things in my free time 
  
I. I quite often (5 — 6 times last week) did physical things in my free time 
  
J. I very often (7 or more times last week) did physical things in my free time 
   
  
9. Mark how often you did physical activity (like playing sports, games, doing dance, or any other 
physical activity) for each day last week.  
 
Monday ..........................       
Tuesday .........................       
Wednesday ....................       
Thursday ........................       
Friday .............................       
Saturday .........................       
Sunday ...........................       
  
10. Were you sick last week, or did anything prevent you from doing your normal physical activities? 
(Check one.)  
Yes ...................................................……  
No ............................................................   
  
 













































11. Please list any sports or physical activities that involve using your hands or arms you have 
participated in regularly. Please tick the boxes to indicate how old you were for each sport/activity and 






12. Please list any sports or physical activities that involve using your hands or arms you have 




Activity:          Sessions/week:   
 
Activity:          Sessions/week:   
 
Activity:          Sessions/week:   
 
Activity:          Sessions/week:   
 
Activity:          Sessions/week:   
 
Activity:          Sessions/week:   
     
Activity:          Sessions/week:   
 
Age:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Activities:
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Name: _______________________                                Date: ____/____/_____ (DD/MM/YY) 
__________________________________________________________________________ 
Limb Dominance, Medication, and Health Questionnaire 
Please answer the following questions to the best of your ability. You may also choose not to 
answer any of these questions.  
1. Which is your dominant hand (e.g., which hand do you write with)?  
Right 
Left 
I can write with both hands 
I don’t know 
 
2. Which is your dominant leg (e.g., which leg do you use to kick a ball)? 
Right 
Left 
I can kick a ball with both legs  
I don’t know  
 





If yes, at what age you were diagnosed with type 1 diabetes? ______________ 
 
If yes, what format of insulin and how many units do you take daily? 
Format ______________ _______________ Units/day_________________ 
Format ______________ _______________ Units/day_________________ 
Format ______________ _______________ Units/day_________________ 
 
4. Are you taking any prescription medications (other than insulin)? 
  Yes 
  No 
  Not Sure  
If yes, how many prescription medications are you taking? _______ 
Name: ____________                  Name: ____________                    Name: ____________ 



















Appendix 5 Transformed Bone Outcomes 
 
Table 6: Mean, standard deviation (SD) of transformed bone properties and strength of DM1 and 








































 DM1 Control  
 Mean SD Mean SD p-value 
Distal Radius      
  ToC 1.861 0.08 1.856 0.08 0.791 
  ToD 2.454 0.06 2.457 0.05 0.775 
  ToA 2.407 0.08 2.399 0.08 0.629 
  TrC 1.753 0.12 1.754 0.11 0.979 
  TrD 2.393 0.05 2.402 0.04 0.358 
  TrA 2.36 0.10 2.352 0.09 0.693 
  BSIc 1.314 0.12 1.313 0.11 0.956 
Radius Shaft      
  ToA 2.074 0.08 2.094 0.08 0.239 
  CoC 1.819 0.07 1.815 0.06 0.778 
  CoD 2.955 0.04 2.921 0.04 <0.001 
  CoA 1.864 0.06 1.894 0.05 0.015 
  SSIp 2.293 0.09 2.273 0.09 0.310 
Distal Tibia      
  ToC 2.317 0.07 2.326 0.06 0.530 
  ToD 2.452 0.04 2.458 0.05 0.563 
  ToA 2.864 0.06 2.868 0.06 0.803 
  TrC 2.209 0.09 2.216 0.09 0.728 
  TrD 2.39 0.04 2.396 0.04 0.506 
  TrA 2.82 0.08 2.821 0.08 0.954 
  BSIc 1.769 0.10 1.784 0.10 0.471 
Tibia Shaft      
  ToA 2.662 0.06 2.687 0.06 0.065 
  CoC 2.34 0.05 2.365 0.05 0.035 
  CoD 2.969 0.02 2.95 0.03 <0.001 
  CoA 2.371 0.05 2.415 0.05 <0.001 
  SSIp 3.133 0.07 3.156 0.08 0.148 
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Appendix 5 Transformed Muscle Outcomes 
Table 7: Mean, standard deviation (SD) of transformed muscle area and neuromuscular 
performance outcomes of DM1 and control groups. The significance of groups differences was 





 DM1 Control  
 Mean SD Mean SD p-value 
Upper Body      
Forearm MuA 1.34 0.05 1.33 0.05 0.450 
Maximal Grip Force 2.27 0.11 2.25 0.10 0.420 
Maximal Push-up Force 2.28 0.09 2.24 0.09 0.045 
Lower Body      
Lower Leg MuA 1.60 0.06 1.62 0.05 0.314 
Countermovement Jump      
  Vertical Force 2.89 0.05 2.92 0.05 0.038 
  Vertical Power 3.16 0.08 3.21 0.08 0.015 
  Vertical Impulse 1.91 0.07 1.94 0.05 0.169 
Long Jump      
  Vertical Force 2.89 0.05 2.90 0.05 0.603 
  Horizontal Force 2.45 0.08 2.43 0.08 0.392 
  Vertical Power 2.95 0.10 2.99 0.09 0.146 
  Horizontal Power 2.68 0.13 2.67 0.12 0.790 
  Vertical Impulse 1.71 0.09 1.73 0.09 0.505 
  Horizontal Impulse 1.92 0.06 1.91 0.05 0.374 
  Length 2.13 0.08 2.12 0.08 0.800 
